Number of new molecular entities launched in the U.S. from 2003 to 2015

Number of new drugs launched in the U.S. 2003-2015 This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more
Loading statistic...
New MechanismOrphanExisting Mechanism
2015141514
201472018
201381711
20121288
2011111210
2010989
20098718
2008767
2007657
20061099
20051146
20041253
20031365
New MechanismOrphanExisting Mechanism
2015141514
201472018
201381711
20121288
2011111210
2010989
20098718
2008767
2007657
20061099
20051146
20041253
20031365
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows the number of new molecular entities launched in the United States from 2003 to 2015. In 2003, a total of 24 new medicines were launched in the United States, six of them were orphan drugs.
Show more
Release date
April 2016
Region
United States
Survey time period
2003 to 2015
Supplementary notes
New Molecular Entity (NME): A novel molecular or biologic entity or combination where at least one element is novel.
This statistic was assembled from several IMS Health reports.
NME launches in the U.S. by year of launch, regardless of timing of FDA approval.
New mechanism: First product with a new mechanism of action for its FDA approved indication.
Orphan: Drugs with one or more orphan indications approved by FDA at launch.
Existing mechanism: Subsequent products with an existing mechanism of action for an indication.
Open this statistic in...

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

U.S. pharmaceutical industry
U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
  • Overview
  • Companies
  • Research and development
The most important statistics
  • Generics
  • Outlook
  • The consumer's view
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News